Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mielnik

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Molecular Psychiatry|August 19, 2020
Consequences of NMDA receptor deficiency can be rescued in the adult brainCatharine A Mielnik, Mary A Binko, Yuxiao Chen, et al.
ACS Chemical Neuroscience|September 13, 2016
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M<sub>1</sub> PAM VU6004256Michael D Grannan, Catharine A Mielnik, Sean P Moran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 9, 2020
A novel allosteric modulator of the cannabinoid CB<sub>1</sub> receptor ameliorates hyperdopaminergia endophenotypes in rodent modelsCatharine A Mielnik, Kim S Sugamori, David B Finlay, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Molecular Psychiatry|August 19, 2020
Consequences of NMDA receptor deficiency can be rescued in the adult brainCatharine A Mielnik, Mary A Binko, Yuxiao Chen, et al.
ACS Chemical Neuroscience|September 13, 2016
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M<sub>1</sub> PAM VU6004256Michael D Grannan, Catharine A Mielnik, Sean P Moran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 9, 2020
A novel allosteric modulator of the cannabinoid CB<sub>1</sub> receptor ameliorates hyperdopaminergia endophenotypes in rodent modelsCatharine A Mielnik, Kim S Sugamori, David B Finlay, et al.
Pageof 3